FR2622106B1 - Nouvelle application therapeutique de derives du 4h-benzo(4,5)cyclo-hepta(1,2-b)thiophene - Google Patents

Nouvelle application therapeutique de derives du 4h-benzo(4,5)cyclo-hepta(1,2-b)thiophene

Info

Publication number
FR2622106B1
FR2622106B1 FR888814001A FR8814001A FR2622106B1 FR 2622106 B1 FR2622106 B1 FR 2622106B1 FR 888814001 A FR888814001 A FR 888814001A FR 8814001 A FR8814001 A FR 8814001A FR 2622106 B1 FR2622106 B1 FR 2622106B1
Authority
FR
France
Prior art keywords
hepta
cyclo
benzo
new therapeutic
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR888814001A
Other languages
English (en)
Other versions
FR2622106A1 (fr
Inventor
Pietro Bollinger
Hans Ulrich Gubler
Jorg Schnyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878725009A external-priority patent/GB8725009D0/en
Priority claimed from GB888803908A external-priority patent/GB8803908D0/en
Priority claimed from GB888820347A external-priority patent/GB8820347D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2622106A1 publication Critical patent/FR2622106A1/fr
Application granted granted Critical
Publication of FR2622106B1 publication Critical patent/FR2622106B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR888814001A 1987-10-26 1988-10-25 Nouvelle application therapeutique de derives du 4h-benzo(4,5)cyclo-hepta(1,2-b)thiophene Expired - Lifetime FR2622106B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878725009A GB8725009D0 (en) 1987-10-26 1987-10-26 Organic compounds
GB888803908A GB8803908D0 (en) 1988-02-19 1988-02-19 Improvements in/relating to organic compounds
GB888820347A GB8820347D0 (en) 1988-08-26 1988-08-26 Improvements in/relating to organic compounds

Publications (2)

Publication Number Publication Date
FR2622106A1 FR2622106A1 (fr) 1989-04-28
FR2622106B1 true FR2622106B1 (fr) 1992-07-10

Family

ID=27263645

Family Applications (1)

Application Number Title Priority Date Filing Date
FR888814001A Expired - Lifetime FR2622106B1 (fr) 1987-10-26 1988-10-25 Nouvelle application therapeutique de derives du 4h-benzo(4,5)cyclo-hepta(1,2-b)thiophene

Country Status (15)

Country Link
US (2) US4956381A (fr)
EP (1) EP0319463A3 (fr)
JP (1) JPH01146819A (fr)
KR (1) KR890012646A (fr)
AU (1) AU616215B2 (fr)
BE (1) BE1005157A3 (fr)
CH (1) CH680112A5 (fr)
DE (1) DE3836329A1 (fr)
DK (1) DK593088A (fr)
FR (1) FR2622106B1 (fr)
GB (1) GB2211407B (fr)
HU (1) HU203198B (fr)
IT (1) IT1224594B (fr)
NL (1) NL8802634A (fr)
SE (1) SE8803793A0 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880610A (en) * 1988-04-20 1989-11-14 Norian Corporation In situ calcium phosphate minerals--method and composition
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment
CA1340994C (fr) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Traitement de maladies et d'etats pathologiques
GB9010332D0 (en) * 1990-05-09 1990-06-27 Sandoz Ltd Improvements in or relating to organic compounds
DK0610336T3 (da) * 1991-10-31 2002-07-22 Univ Manchester Behandling af neurologiske tilstande ved hjælp af en interleukin-1-hæmmende forbindelse
JP3286831B2 (ja) * 1996-04-01 2002-05-27 エーザイ株式会社 ビタミンｂ２含有医薬
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
FR2784031B1 (fr) * 1998-10-02 2002-02-01 Sanofi Elf Utilisation de derives de l'acide bisphosphonique pour la preparation d'un medicament destine au traitement des boiteries
WO2002074313A1 (fr) 2001-03-21 2002-09-26 Eisai Co., Ltd. Médicaments à base de vitamine b2 réduite
AT510837B1 (de) 2011-07-27 2012-07-15 Helmut Dr Buchberger Inhalatorkomponente
EP2672847B1 (fr) 2011-02-11 2015-04-22 Batmark Limited Élément inhalateur
WO2013034460A1 (fr) 2011-09-06 2013-03-14 British American Tobacco (Investments) Limited Chauffage de matériau fumable
KR102060691B1 (ko) 2011-09-06 2020-02-11 브리티시 아메리칸 토바코 (인베스트먼츠) 리미티드 가열식 흡연가능 재료
GB201207039D0 (en) 2012-04-23 2012-06-06 British American Tobacco Co Heating smokeable material
GB201407426D0 (en) 2014-04-28 2014-06-11 Batmark Ltd Aerosol forming component
GB2533135B (en) 2014-12-11 2020-11-11 Nicoventures Holdings Ltd Aerosol provision systems
GB201511349D0 (en) 2015-06-29 2015-08-12 Nicoventures Holdings Ltd Electronic aerosol provision systems
US20170055584A1 (en) 2015-08-31 2017-03-02 British American Tobacco (Investments) Limited Article for use with apparatus for heating smokable material
US11924930B2 (en) 2015-08-31 2024-03-05 Nicoventures Trading Limited Article for use with apparatus for heating smokable material
US20170119046A1 (en) 2015-10-30 2017-05-04 British American Tobacco (Investments) Limited Apparatus for Heating Smokable Material
MY192211A (en) 2016-04-27 2022-08-08 Nicoventures Trading Ltd Electronic aerosol provision system and vaporizer therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195800B (en) * 1983-10-13 1988-07-28 Sandoz Ltd Process for producing 4h-benzo/4,5/cylopenta/1,2-b/ thiofene derivatives and pharmaceutical compositions containing them
GB8530245D0 (en) * 1985-12-09 1986-01-22 Sandoz Ltd Organic compounds
US4692460A (en) * 1986-12-24 1987-09-08 Mcneilab, Inc. Cyclopenta[b]thiophenes having anti-inflammatory activity similar to steroids

Also Published As

Publication number Publication date
SE8803793D0 (sv) 1988-10-24
HU203198B (en) 1991-06-28
IT8848491A0 (it) 1988-10-26
DE3836329A1 (de) 1989-05-03
EP0319463A3 (fr) 1990-10-10
US5096921A (en) 1992-03-17
AU2417588A (en) 1989-04-27
KR890012646A (ko) 1989-09-18
GB2211407B (en) 1991-10-16
FR2622106A1 (fr) 1989-04-28
US4956381A (en) 1990-09-11
GB2211407A (en) 1989-07-05
CH680112A5 (fr) 1992-06-30
JPH01146819A (ja) 1989-06-08
BE1005157A3 (fr) 1993-05-11
GB8824887D0 (en) 1988-11-30
NL8802634A (nl) 1989-05-16
IT1224594B (it) 1990-10-04
AU616215B2 (en) 1991-10-24
DK593088A (da) 1989-04-27
SE8803793A0 (sv) 1989-04-27
EP0319463A2 (fr) 1989-06-07
DK593088D0 (da) 1988-10-25
HUT51485A (en) 1990-05-28

Similar Documents

Publication Publication Date Title
FR2622106B1 (fr) Nouvelle application therapeutique de derives du 4h-benzo(4,5)cyclo-hepta(1,2-b)thiophene
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
FR2343748A1 (fr) Derives de 2,3-dihydro imidazo (2,1-b) thiazole, leur procede de preparation et leur application en therapeutique
EG18544A (en) Six - membred heterocyclic derivatives of n', - substituted - n, n'-diacylhydrazines
EP0261755A3 (en) Five-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines
DK360888D0 (da) 3',4'-dinitrogen-substituerede epipodophyllotoxinglucosidderivater
MC1918A1 (fr) Derives de l'imidazodiazepine
DK400388A (da) Thienderivater
IT1214756B (it) Derivati del 4h-benzo[4,5]cicloepta [1,2-b]tiofene,loro preparazione eloro impiego come medicamenti
KR890701553A (ko) 시스테인의 신규 유도체
MC1848A1 (fr) Derives de l'isoprene
DE69002136D1 (de) Saccharidderivate von protocatechualdehyd.
FI904673A0 (fi) 2,6-dioksopiperidiinijohdannaisten valmistus
MC2052A1 (fr) Derives de l'imidazodiazepine
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi
BE872250A (fr) Application en therapeutique de derives 3'-methoxy-flavylium substitues
FR2602233B1 (fr) Derives de l'isoquinoleine
NO934267L (no) Nye tiofenderivater
FI881327A (fi) Menetelmä bentso(kalkogeno)/4,3,2-cd/indatsolien valmistamiseksi
FI903735A0 (fi) Furo/3,4-c/pyridiinijohdosten asymmetrinen synteesi
FR2604176B1 (fr) Derives fonctionnels du 7-oxabicyclo(2.2.1)heptane a action therapeutique
MC1816A1 (fr) Derives d'isoquinoleine
FR2617165B1 (fr) Derives du dimethyl-2, 2 chromannol-3
IT8847797A0 (it) Derivati dell' 1.3 -diossalano e dell'1.3-diossano e loro impiegocome medicamenti
PL106896B1 (pl) Sposob wytwarzania nowych biologicznie czynnych pochodnych pirazolo-/3,4-b/-pirydyny

Legal Events

Date Code Title Description
ST Notification of lapse